Daré Bioscience, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €8.43K -99.7% -€3.49M -86.6% -41,435.0% -400 pp €5.14M -115.6% 60,990.3% +620 pp
    €2.42M -71.9% -€25.97M -2.5% -1,074.1% -7.6 pp -€32.92M +112.1% -1,361.4% -12 pp
    €8.61M +∞% -€26.65M -19.3% -309.5% -3.1 pp -€15.52M -37.3% -180.3% -1.8 pp
    €0.00 +NaN% -€33.01M +39.9% N/A -€24.76M +14.0% N/A
    €0.00 +NaN% -€23.60M +92.1% N/A -€21.72M +89.4% N/A
    €0.00 +NaN% -€12.28M -14.8% N/A -€11.47M +29.8% N/A
    €0.00 +NaN% -€14.42M +45.5% N/A -€8.83M +303.8% N/A
    €0.00 -100.0% -€9.91M -70.7% N/A -€2.19M -92.3% N/A
    €659.66K +∞% -€33.85M -0.7% -5,131.2% -51 pp -€28.42M +4.3% -4,308.2% -43 pp
    €0.00 -100.0% -€34.10M +69.6% N/A -€27.25M +68.0% N/A
    €68.89K +1,233.3% -€20.10M +36.2% -29,177.5% +2.6K pp -€16.22M +13.4% -23,545.0% +2.5K pp
    €5.17K -99.0% -€14.76M -22.4% -285,716.7% -2.8K pp -€14.30M -20.3% -276,783.3% -2.7K pp
    €538.24K +104.9% -€19.03M +13.0% -3,536.2% +29 pp -€17.93M +25.0% -3,332.0% +21 pp
    €262.66K -€16.85M -6,414.1% -€14.35M -5,462.6%

    Notifications